C Klabunde

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Bethesda, MD 20892 7344, USA
    Ann Epidemiol 17:584-90. 2007
  2. ncbi Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Med Care 43:939-44. 2005
  3. ncbi Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Med Care 43:391-400. 2005
  4. ncbi Health plan policies and programs for colorectal cancer screening: a national profile
    Carrie N Klabunde
    Division of Cancer Control and Population Sciences, National Cancer Institute NCI, Executive Plaza North Room 4005, 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
    Am J Manag Care 10:273-9. 2004
  5. ncbi A national survey of primary care physicians' colorectal cancer screening recommendations and practices
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Bethesda, MD 20892, USA
    Prev Med 36:352-62. 2003
  6. ncbi Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries
    Carrie N Klabunde
    National Cancer Institute, Health Services and Economics Branch, Bethesda, MD 20892 7344, USA
    Int J Qual Health Care 14:449-61. 2002
  7. ncbi Assessing comorbidity using claims data: an overview
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Med Care 40:IV-26-35. 2002
  8. ncbi Quality assurance for screening mammography: an international comparison
    C Klabunde
    National Cancer Institute NCI, Bethesda 20892 7344, USA
    J Epidemiol Community Health 55:204-12. 2001
  9. ncbi Development of a comorbidity index using physician claims data
    C N Klabunde
    Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North Room 4005, 6130 Executive Boulevard MSC 7344, Bethesda, MD, USA
    J Clin Epidemiol 53:1258-67. 2000
  10. ncbi Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment
    R Ballard-Barbash
    National Cancer Institute, Bethesda, MD 20892 7344, USA
    Eur J Cancer Prev 8:417-26. 1999

Detail Information

Publications11

  1. ncbi A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Bethesda, MD 20892 7344, USA
    Ann Epidemiol 17:584-90. 2007
    ....
  2. ncbi Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Med Care 43:939-44. 2005
    ..Barriers to colorectal cancer (CRC) screening are not well understood...
  3. ncbi Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Med Care 43:391-400. 2005
    ..Comorbidity is an important dimension of patient health status. However, limited attention has been given to assessing the reliability of patient-reported data on comorbid conditions...
  4. ncbi Health plan policies and programs for colorectal cancer screening: a national profile
    Carrie N Klabunde
    Division of Cancer Control and Population Sciences, National Cancer Institute NCI, Executive Plaza North Room 4005, 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
    Am J Manag Care 10:273-9. 2004
    ..A consensus has emerged that average-risk adults 50 years of age or older should be screened for colorectal cancer (CRC)...
  5. ncbi A national survey of primary care physicians' colorectal cancer screening recommendations and practices
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Bethesda, MD 20892, USA
    Prev Med 36:352-62. 2003
    ....
  6. ncbi Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries
    Carrie N Klabunde
    National Cancer Institute, Health Services and Economics Branch, Bethesda, MD 20892 7344, USA
    Int J Qual Health Care 14:449-61. 2002
    ....
  7. ncbi Assessing comorbidity using claims data: an overview
    Carrie N Klabunde
    Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
    Med Care 40:IV-26-35. 2002
    ..The assessment of comorbidity using claims data is a complex and evolving area of investigation...
  8. ncbi Quality assurance for screening mammography: an international comparison
    C Klabunde
    National Cancer Institute NCI, Bethesda 20892 7344, USA
    J Epidemiol Community Health 55:204-12. 2001
    ..In 1998, the International Breast Cancer Screening Network (IBSN) sponsored an assessment of quality assurance policies and practices to define their scope for population-based screening mammography programmes across IBSN countries...
  9. ncbi Development of a comorbidity index using physician claims data
    C N Klabunde
    Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North Room 4005, 6130 Executive Boulevard MSC 7344, Bethesda, MD, USA
    J Clin Epidemiol 53:1258-67. 2000
    ..The physician claims index can be used in conjunction with a comorbidity index derived from inpatient hospital claims, or employed as a stand-alone measure...
  10. ncbi Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment
    R Ballard-Barbash
    National Cancer Institute, Bethesda, MD 20892 7344, USA
    Eur J Cancer Prev 8:417-26. 1999
    ..In conclusion, diversity exists in the organization and delivery of screening mammography internationally. Quality assurance activities are a priority and are being evaluated in the IBSN...
  11. ncbi US physicians' attitudes toward genetic testing for cancer susceptibility
    A N Freedman
    Division of Cancer Control and Population Sciences, National Cancer Institute NIH, EPN 4005 MSC 7344, 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
    Am J Med Genet A 120:63-71. 2003
    ..Results of this national survey underscore the need to provide physicians with clear guidelines on the use of genetic cancer susceptibility tests and effective medical training on their appropriate implementation...